Response measurement after intraarterial chemoradiation in advanced head and neck carcinoma: Magnetic resonance imaging and evaluation under general anesthesia?

Cancer

Volumn 106, Issue 8, 2006, Pages 1722-1729

  Van Den Broek, Guido B ^a,b   Rasch, Coen R N ^a   Pameijer, Frank A ^a   Peter, Ellen ^a   Van Den Brekel, Michiel W M ^a,b   Balm, Alfons J M ^a,b  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Chemoradiation; Head and neck neoplasms; Intraarterial cisplatin and concomitant radiation; Intraarterial infusions; Magnetic resonance imaging; Posttreatment evaluation

Indexed keywords

CISPLATIN; SODIUM THIOSULFATE;

ADVANCED CANCER; ARTICLE; CANCER CONTROL; CANCER GRADING; CANCER RECURRENCE; GENERAL ANESTHESIA; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; MAJOR CLINICAL STUDY; MOUTH CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TUMOR BIOPSY;

ANESTHESIA, GENERAL; ANTINEOPLASTIC AGENTS; BIOPSY; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MAGNETIC RESONANCE IMAGING; MALE; MOUTH NEOPLASMS; NEOPLASM, RESIDUAL; OTORHINOLARYNGOLOGIC NEOPLASMS; PREDICTIVE VALUE OF TESTS;

EID: 33646026457     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21786     Document Type: Article

References (32)

1. Adelstein DJ, Li Y, Adams GL, et al. An intergroup Phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21:92-98.
2. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;338:1798-1804.
3. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999;91:2081-2086.
4. Denis F, Garaud P, Bardet E, et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol. 2004;22:69-76.
5. Jeremic B, Shibamoto Y, Stanisavljevic B, Milojevic L, Milicic B, Nikolic N. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. Radiother Oncol. 1997;43:29-37.
6. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC collaborative group. Meta-analysis of chemotherapy on head and neck cancer. Lancet. 2000;355:949-955.
7. Wendt TG, Grabenbauer GG, Rodel CM, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol. 1998;16:1318-1324.
8. Balm AJ, Rasch CR, Schornagel JH, et al. High-dose super-selective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck. 2004;26:485-493.
9. Glazer HS, Niemeyer JH, Balfe DM, et al. Neck neoplasms: MR imaging. Part II. Posttreatment evaluation. Radiology. 1986;160:349-354.
10. Lell M, Baum U, Greess H, et al. Head and neck tumors: imaging recurrent tumor and post-therapeutic changes with CT and MRI. Eur J Radiol. 2000;33:239-247.
11. Hermans R, Pameijer FA, Mancuso AA, Parsons JT, Mendenhall WM. Laryngeal or hypopharyngeal squamous cell carcinoma: can follow-up CT after definitive radiation therapy be used to detect local failure earlier than clinical examination alone? Radiology. 2000;214:683-687.
12. Pameijer FA, Hermans R, Mancuso AA, et al. Pre- and postradiotherapy computed tomography in laryngeal cancer: imaging-based prediction of local failure. Int J Radiat Oncol Biol Phys. 1999;45:359-366.
13. Robbins KT, Kumar P, Wong FS, et al. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck. 2000;22:687-693.
14. Robbins KT, Kumar P, Harris J, et al. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of Stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615. J Clin Oncol. 2005;23:1447-1454.
15. Robbins KT, Kumar P, Regine WF, et al. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys. 1997;38:263-271.
16. Ojiri H, Mendenhall WM, Mancuso AA. CT findings at the primary site of oropharyngeal squamous cell carcinoma within 6-8 weeks after definitive radiotherapy as predictors of primary site control. Int J Radiat Oncol Biol Phys. 2002;52:748-754.
17. Sobin LH, Wittekind C, editors. TNM classification of malignant tumors. 5th ed. New York: John Wiley & Sons; 1997.
18. van den Broek GB, Rasch CR, Pameijer FA, et al. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma. Cancer. 2004;101:1809-1817.
19. Cox DR. Regression models and life-tables. J R Stat Soc. 1972;34:187-220.
20. Mukherji SK, Mancuso AA, Kotzur IM, et al. Radiologic appearance of the irradiated larynx. Part I. Expected changes. Radiology. 1994;193:141-148.
21. Mukherji SK, Mancuso AA, Kotzur IM, et al. Radiologic appearance of the irradiated larynx. Part II. Primary site response. Radiology. 1994;193:149-154.
22. Kitagawa Y, Nishizawa S, Sano K, et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med. 2003;44:198-206.
23. Kubota K, Yokoyama J, Yamaguchi K, et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imag. 2004;31:590-595.
24. Valentino J, Spring PM, Shane M, Arnold SM, Regine WF. Interval pathologic assessments in patients treated with concurrent hyperfractionated radiation and intraarterial cisplatin (HYPERRADPLAT). Head Neck. 2002;24:539-544.
25. Mukherji SK, O'Brien SM, Gerstle RJ, et al. The ability of tumor volume to predict local control in surgically treated squamous cell carcinoma of the supraglottic larynx. Head Neck. 2000;22:282-287.
26. Mancuso AA, Mukherji SK, Schmalfuss I, et al. Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma. J Clin Oncol. 1999;17:631-637.
27. Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Mancuso AA. Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck. 2003;25:535-542.
28. Pameijer FA, Mancuso AA, Mendenhall WM, Parsons JT, Kubilis PS. Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy? Int J Radiat Oncol Biol Phys. 1997;37:1011-1021.
29. Doweck I, Denys D, Robbins KT. Tumor volume predicts outcome for advanced head and neck cancer treated with targeted chemoradiotherapy. Laryngoscope. 2002;112:1742-1749.
30. Lowe VJ, Boyd JH, Dunphy FR, et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol. 2000;18:651-658.
31. Mukherji SK, Gapany M, Phillips D, et al. Thallium-201 single-photon emission CT versus CT for the detection of recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol. 1999;20:1215-1220.
32. Wong RJ, Lin DT, Schoder H, et al. Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol. 2002;20:4199-4208.